The short version
11 companies supply this market — deep enough that no single failure threatens the supply. The price is down 23% over the past year, to $18.12 per mL. One of its named manufacturing plants, Sun Pharmaceutical Industries Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 0.6% of the time — roughly 4× the typical drug (0.1%).
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.